These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30773817)

  • 1. Higher serum levels of systemic inflammatory markers are linked to greater inspiratory muscle dysfunction in COPD.
    Formiga MF; Vital I; Urdaneta G; Masters B; Herrera J; Campos MA; Cahalin LP
    Clin Respir J; 2019 Apr; 13(4):247-255. PubMed ID: 30773817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond inspiratory muscle strength: Clinical utility of single-breath work capacity assessment in veterans with COPD.
    Formiga MF; Vital I; Urdaneta G; Campos MA; Cahalin LP
    Respir Med; 2019 Feb; 147():13-18. PubMed ID: 30704693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of the test of incremental respiratory endurance measures of inspiratory muscle performance in COPD.
    Formiga MF; Roach KE; Vital I; Urdaneta G; Balestrini K; Calderon-Candelario RA; Campos MA; Cahalin LP
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1569-1576. PubMed ID: 29805255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of inspiratory muscle endurance testing using PowerBreathe for COPD patients.
    Basso-Vanelli RP; Di Lorenzo VAP; Ramalho M; Labadessa IG; Regueiro EMG; Jamami M; Costa D
    Physiother Res Int; 2018 Jan; 23(1):. PubMed ID: 28394092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home-based pulmonary rehabilitation improves clinical features and systemic inflammation in chronic obstructive pulmonary disease patients.
    do Nascimento ES; Sampaio LM; Peixoto-Souza FS; Dias FD; Gomes EL; Greiffo FR; Ligeiro de Oliveira AP; Stirbulov R; Vieira RP; Costa D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():645-53. PubMed ID: 25848241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive end-expiratory pressure attenuates hemodynamic effects induced by an overload of inspiratory muscles in patients with COPD.
    Schaper-Magalhães F; Pinho JF; Capuruço CAB; Rodrigues-Machado MG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2943-2954. PubMed ID: 29062231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory muscle strength during and after hospitalization for COPD exacerbation.
    Mesquita R; Donária L; Genz IC; Pitta F; Probst VS
    Respir Care; 2013 Dec; 58(12):2142-9. PubMed ID: 23716708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
    Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
    Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A temporal examination of inspiratory muscle strength and endurance in hospitalized COVID-19 patients.
    Dosbaba F; Hartman M; Batalik L; Senkyr V; Radkovcova I; Richter S; Brat K; Cahalin LP; Formiga MF
    Heart Lung; 2023; 60():95-101. PubMed ID: 36934476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Inspiratory Muscle Weakness a Determinant of Endurance Exercise Tolerance During NIV-Supported Exercise in Patients With COPD?
    Koch R; Rapello GVG; de Tarso Müller P
    J Cardiopulm Rehabil Prev; 2018 Nov; 38(6):E9-E11. PubMed ID: 29652758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory muscles in COPD: regulation of trophical status.
    Decramer M
    Verh K Acad Geneeskd Belg; 2001; 63(6):577-602; discussion 602-4. PubMed ID: 11813511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary function and functional capacity cut-off point to establish sarcopenia and dynapenia in patients with COPD.
    Mansour KMK; Goulart CDL; Carvalho-Junior LCS; Trimer R; Borghi-Silva A; Silva ALGD
    J Bras Pneumol; 2019; 45(6):e20180252. PubMed ID: 31644702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inspiratory muscle strength, diaphragmatic mobility, and body composition in chronic obstructive pulmonary disease.
    Souza RMP; Cardim AB; Maia TO; Rocha LG; Bezerra SD; Marinho PÉM
    Physiother Res Int; 2019 Apr; 24(2):e1766. PubMed ID: 30628141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cycle ergometer and inspiratory muscle training offer modest benefit compared with cycle ergometer alone: a comprehensive assessment in stable COPD patients.
    Wang K; Zeng GQ; Li R; Luo YW; Wang M; Hu YH; Xu WH; Zhou LQ; Chen RC; Chen X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2655-2668. PubMed ID: 28919733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Inspiratory Muscle Training and Calisthenics-and-Breathing Exercises in COPD With and Without Respiratory Muscle Weakness.
    Basso-Vanelli RP; Di Lorenzo VA; Labadessa IG; Regueiro EM; Jamami M; Gomes EL; Costa D
    Respir Care; 2016 Jan; 61(1):50-60. PubMed ID: 26556894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between inspiratory muscle weakness and slowed oxygen uptake kinetics in patients with chronic obstructive pulmonary disease.
    Wolpat A; Lima FV; Silva FM; Tochetto M; de Freitas A; Grandi T; Rodrigues L; Paiva V; Cipriano G; Chiappa AM; Zago J; Chiappa GR
    Appl Physiol Nutr Metab; 2017 Dec; 42(12):1239-1246. PubMed ID: 28750180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of maximal inspiratory pressure: determination in COPD exacerbation.
    Tudorache V; Oancea C; Mlădinescu OF
    Int J Chron Obstruct Pulmon Dis; 2010 May; 5():119-23. PubMed ID: 20461143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of inflammatory biomarkers in patients with COPD: a comparison of different assays.
    López-Campos JL; Arellano E; Calero C; Delgado A; Márquez E; Cejudo P; Ortega F; Rodríguez-Panadero F; Montes-Worboys A
    BMC Med Res Methodol; 2012 Mar; 12():40. PubMed ID: 22463705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inspiratory muscle activation increases with COPD severity as confirmed by non-invasive mechanomyographic analysis.
    Sarlabous L; Torres A; Fiz JA; Martínez-Llorens JM; Gea J; Jané R
    PLoS One; 2017; 12(5):e0177730. PubMed ID: 28542364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients.
    Zhang M; Li Y; Yang X; Shan H; Zhang Q; Ming Z; Xie Y; Chen H; Liu Y; Zhang J
    Inflammation; 2016 Apr; 39(2):625-31. PubMed ID: 26613760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.